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PENYEDIAAN MIKROSFERA POLI(ASID LAKTIK) (PLA) UNTUK SISTEM 
PENGHANTARAN UBAT 
ABSTRAK 
Poli(asid laktik) (PLA) mikrosfera telah berjaya disediakan melalui kaedah emulsi dan 
pemeruapan pelarut (ESE). Taburan saiz partikel (PSD) mikrosfera yang diperoleh adalah 
dalam lingkungan 1 - 250 µm, merupakan lingkungan saiz yang boleh diterima bagi 
penghantaran jenis suntikan “parenteral”. Kaedah “shake flask” dibuktikan sebagai teknik 
alternatif untuk menentukan kebolehlaksanaan pengkapsulan sesuatu ESE sistem. Dalam 
projek ini, pasangan pelarut diklorometana-air telah digunakan dalam sistem shake flask 
untuk mensimulasikan sistem ESE, dan Rhodamine B telah digunakan sebagai model ubat 
sepanjang projek ini. Parameter yang dikaji dalam fabrikasi mikrosfera adalah kepekatan 
PLA, kepekatan PVA dan nisbah isipadu fasa teragih (DP). Kesan parameter pada PSD, 
morfologi permukaan dan kecekapan pengkapsulan telah dinilai. Formulasi optimun adalah 
pada 25% DP, 15% PLA dan 1% PVA, yang mana hasil mikrosfera tertinggi diperolehi 
dengan penggunaan PVA terendah dalam ESE sistem dan taburan partikel saiz diperolehi 
dalam 1- 50 μm. Bagi formulasi ini, pembusaan emulsi telah diperhatikan semasa 
pengacauan dalam proses pengemulsian. Dicadangkan bahawa, titisan yang tersebar dalam 
emulsi lebih cenderung berada dalam struktur buih yang seterusnya memberikan kestabilan 
tambahan antara titisan atau partikel separuh keras tersebut. Teknik hidrolisis pengaruh 
pemangkin telah digunakan untuk mengubahsuaian permukaan mikrosfera. Kajian atas 
sifat-sifat permukaan dan pukal telah dijalankan untuk mengesahkan keberkesanan teknik 
hidrolisis. Secara keseluruhan, faktor-faktor termasuk skala masa, jenis pemangkin dan 
kepekatan pemangkin harus dimanipulasi untuk mendapatkan sifat permukaan yang 
dikehendaki (contohnya, hidrofilik, caj dan morfologi permukaan) dengan ubah bentuk 
sifat pukal mikrosfera yang minimum.  
xx 
 
PREPARATION OF POLY(LACTIC ACID) (PLA) MICROSPHERES FOR DRUG 
DELIVERY SYSTEM 
ABSTRACT 
Poly(lactic acid) (PLA) microspheres were fabricated through emulsion and solvent 
evaporation (ESE) technique. The particle size distributions (PSD) of microspheres 
obtained were in the range of 1- 250 µm, as within the range of acceptable size in 
parenteral injection. A shake flask method was demonstrated as an alternative technique to 
determine the encapsulation feasibility of an ESE system. Herein, dichloromethane-water 
solvent pair was used in shake flask system in order to simulate ESE system, and 
Rhodamine B was utilized as model drug throughout the project. In the fabrication of 
microspheres, the studies parameters were included PLA concentration, PVA 
concentration and dispersed phase volume ratio (DP). The effect of parameters on PSD 
range, surface morphology and encapsulation efficiency were evaluated. The optimum 
formulation was at 25 % DP, 15 % PLA and 1 % PVA, wherein the highest output of 
microspheres obtained at lowest PVA consumption in the system and narrow PSD obtained 
in range 1- 50 µm. In this formulation, extensive foaming of emulsion was observed during 
the emulsification process. It was suggested that the dispersed droplets tends to stay within 
the foam structure which further provide extra stabilization between droplets or partial 
solidified particles. The surfaces of microspheres were modified through catalytic induced 
hydrolysis technique. The surface and bulk properties of treated microspheres were 
investigated to verify the effectiveness of hydrolysis technique. Results demonstrated that 
the factors included timescale, type of catalyst and concentration should be manipulated in 
order to obtain the desired surface properties (e.g. hydrophilicity, surface charges and 
surface morphology) with minium deformation in microspheres bulk propertie
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Chapter 1 
Introduction 
1.1 Overview 
 Drug delivery system is defined as the device which encapsulated with specific 
amount of drug further delivery it in a controlled or sustained manner upon the 
administration. In pharmaceutical, it is urged to have the suitable drug delivery system that 
able to maintain the blood drug concentration lies between the minimum effective and 
maximum toxic concentration (Uchizono, 2006, Liechty et al., 2010). In order to deliver 
drugs to diseased site in the body in a more effective and less invasive way, a new dosage 
form technology of drug delivery has emerged in the late 1960’s (Coelho et al., 2010).  
 There are variable approached in designing an effective drug delivery system by 
using polymeric materials either in natural or synthetic forms. One of the promising design 
is used of biodegradable microspheres prepared from polyester, such as poly(lactic acid) 
(PLA), poly(glycolic acid) and their copolymer poly(lactic-co-glycolic). They are mostly 
focusing on the encapsulation of large molecules, e.g., peptides, proteins and plasmid 
Deoxyribo Nucleic Acid (DNA) for potential used as vaccines or as long-acting release 
drug formulation. The major advantages of biodegradable systems are they was eventually 
absorbed or excreted by the body. The drug release of microspheres was controlled by the 
polymer degradation rate and particle size of microspheres (Ulery et al., 2011). One of the 
major considerations in microspheres fabrication was the particle size distribution as it 
determined the drug administration route, drug release properties, patient compliance and 
safety during the application period (Berkland et al., 2002).  
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 Drug loaded microspheres are prepared through microencapsulation technique. 
Microencapsulation, is the term used to describe the technique to surround or coat certain 
chemical entity (in the form of either solids, liquids or gaseous) within a material that able 
to release the contents at certain conditions (upon moisture, pH, physical force or 
combination thereof) (Luzzi, 1970, Chanana et al., 2013). It has been reported that 
emulsion and solvent evaporation technique is most successful to load either insoluble or 
poorly soluble drugs in biodegradable microspheres (O'Donnell and McGinity, 1997). The 
effectiveness of microspheres preparation technique for drug delivery usage is depends on 
the successful entrapment of the drug within the particles. The understanding ESE 
technique from the aspect of intrinsic (interaction between materials) and extrinsic 
(adjustable parameters such as stirring speed, water-in-oil phase ratio, drug loading, 
polymer and stabilizer concentration) are crucial in order to produce microspheres with 
desired drug encapsulation.  
 Another consideration involved in designing an effective drug delivery system is 
the surface properties of microspheres. Generally, the surfaces of polyester based 
biodegradable microspheres are recognized as non-biocompatible because of hydrophobic 
in nature and lacking of bio-recognized functional group or molecules. These might cause 
rapid elimination of microspheres in the biological system prior drug release from 
microspheres (Stolnik et al., 1995). Material surfaces can be modified by a variety of 
different methods, such as the application of a surface chemical gradient, self-assembled 
films, surface-active bulk additive and surface chemical reaction. Microspheres surfaces 
are required to be modified with various functional groups such as methyl-, hydroxyl-, 
amino-, and carboxyl, all of which can be found on natural biological surfaces in order to 
optimize the function of microspheres as drug delivery system (Roach et al., 2007). 
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1.2 Problem Statements:   
 Emulsion and solvent evaporation (ESE) was selected as microspheres fabrication 
technique, because this technique is conceptually simple in experimental setup. However, 
the quality of microspheres (e.g. particle size, drug loading, agglomerate and etc.) prepared 
from this technique are highly dependent on the system nature. Despite the widespread use 
of this technique, encapsulation methodologies are still largely based on trial and error. 
More quantitative theory and experiments are required to improve our understanding of 
how the encapsulation conditions affect the final particle characteristics. Therefore, at the 
preliminary stage of microsphere fabrication the establishment and understanding of ESE 
technique are required.  
 The encapsulation feasibility of the ESE process is highly dependent on the 
materials interaction and the materials’ properties. As illustrated in Fig. 1.1, the feasibility 
of the system to encapsulate certain chemical substance in PLA microspheres can only be 
determined if the series of ESE process was run and the obtained microspheres were 
characterized. Therefore, an alternative approaches was proposed to determine the 
encapsulation feasibility to eliminate this trial-and-error procedure. In this research, a 
shake flask method was proposed to tackle this issue. In this shake flask approach, if the 
drug has higher affinity toward the polymer’s solvent in shake flask system, then this drug 
is able to be encapsulating within the microspheres in through ESE technique.  
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Fig. 1.1: Shake flask method proposed to replace the ESE processes during the 
determination of encapsulation feasibility 
 
 Particle size distribution of microspheres is crucial in drug delivery purposes. 
Unfortunately, the main issue of using the ESE technique in microspheres fabrication was 
the broad particle size distribution. Various approaches have been conducted to narrow the 
PSD, through either high stirring forces by homogenizer and sonication, or through highly 
controllable electrohydrodynamic atomization and membrane emulsification (Liu et al., 
2011, Vauthier and Bouchemal, 2009, Pareta and Edirisinghe, 2006, Sawalha et al., 2008). 
However, the mentioned modified techniques are required extra machinery setup or 
exposed the risk of emulsion heat up that induces the deterioration of drug (Freitas et al., 
2005). Therefore, it is desired to improve the ESE system which able to narrow the particle 
size distribution without possessing any difficulty in either the fabrication process or drug 
deterioration.  
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